Shahryar Shakeri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shahryar Shakeri has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Fatemeh Karimi
3 shared publicationsKhalil Tabatabaeian
3 shared publicationsAbdollah Fallah Shojaei
2 shared publications- Hadi Beitollahi
Environment Department, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran
2 shared publications - Mahmood Maleki
Department of Biotechnology, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran
2 shared publications - Abbas Pardakhty
Pharmaceutics Research Center, Institute of Pharmaceutical Sciences, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication
Latest Publications
- Open Access
- 15 April 2021
- Published by Springer Nature in Biotechnology for Biofuels
- Vol. 14 (1) , 1-14
Rhodosporidium sp. DR37: a novel strain for production of squalene in optimized cultivation conditions
Background: Rhodosporidium strain, a well-known oleaginous yeast, has been widely used as a platform for lipid and carotenoid production. However, the production of squalene for application in lipid-based biofuels is not reported in this strain. Here, a new strain of Rhodosporidium sp. was isolated and identified, and its potential was investigated for production of squalene under various cultivation conditions. Results: In the present study, Rhodosporidium sp. DR37 was isolated from mangrove ecosystem and its potential for squalene production was assessed. When Rhodosporidium sp. DR37 was cultivated on modified YEPD medium (20 g/L glucose, 5 g/L peptone, 5 g/L YE, seawater (50% v/v), pH 7, 30 °C), 64 mg/L of squalene was produced. Also, squalene content was obtained as 13.9% of total lipid. Significantly, use of optimized medium (20 g/L sucrose, 5 g/L peptone, seawater (20% v/v), pH 7, 25 °C) allowed highest squalene accumulation (619 mg/L) and content (21.6% of total lipid) in Rhodosporidium sp. DR37. Moreover, kinetic parameters including maximum specific cell growth rate (μmax, h−1), specific lipid accumulation rate (qp, h−1), specific squalene accumulation rate (qsq, h−1) and specific sucrose consumption rate (qs, h−1) were determined in optimized medium as 0.092, 0.226, 0.036 and 0.010, respectively. Conclusions: This study is the first report to employ marine oleaginous Rhodosporidium sp. DR37 for accumulation of squalene in optimized medium. These findings provide the potential of Rhodosporidium sp. DR37 for production of squalene as well as lipid and carotenoids for biofuel applications in large scale. Graphic
- 15 April 2021
- Published by Springer Nature in Biotechnology for Biofuels
- Vol. 14 (1) , 1-14
Open AccessRhodosporidium sp. DR37: a novel strain for production of squalene in optimized cultivation conditions
Background: Rhodosporidium strain, a well-known oleaginous yeast, has been widely used as a platform for lipid and carotenoid production. However, the production of squalene for application in lipid-based biofuels is not reported in this strain. Here, a new strain of Rhodosporidium sp. was isolated and identified, and its potential was investigated for production of squalene under various cultivation conditions. Results: In the present study, Rhodosporidium sp. DR37 was isolated from mangrove ecosystem and its potential for squalene production was assessed. When Rhodosporidium sp. DR37 was cultivated on modified YEPD medium (20 g/L glucose, 5 g/L peptone, 5 g/L YE, seawater (50% v/v), pH 7, 30 °C), 64 mg/L of squalene was produced. Also, squalene content was obtained as 13.9% of total lipid. Significantly, use of optimized medium (20 g/L sucrose, 5 g/L peptone, seawater (20% v/v), pH 7, 25 °C) allowed highest squalene accumulation (619 mg/L) and content (21.6% of total lipid) in Rhodosporidium sp. DR37. Moreover, kinetic parameters including maximum specific cell growth rate (μmax, h−1), specific lipid accumulation rate (qp, h−1), specific squalene accumulation rate (qsq, h−1) and specific sucrose consumption rate (qs, h−1) were determined in optimized medium as 0.092, 0.226, 0.036 and 0.010, respectively. Conclusions: This study is the first report to employ marine oleaginous Rhodosporidium sp. DR37 for accumulation of squalene in optimized medium. These findings provide the potential of Rhodosporidium sp. DR37 for production of squalene as well as lipid and carotenoids for biofuel applications in large scale. Graphic
- Open Access
- 26 January 2021
- Published by Springer Nature in Research Square
Rhodosporidium Sp. DR37: A Novel Strain For Production of Squalene in Optimized Cultivation Conditions
Background: Rhodosporidium strain, a well-known oleaginous yeast, has been widely used as a platform for lipid and carotenoid production. However, the production of squalene for application in lipid-based biofuels is not reported in this strain. Here, we isolated and identified newly strain of Rhodosporidium sp. DR37 and investigated its potential for production of squalene under various cultivation conditions.Results: In the present study, Rhodosporidium sp. DR37 was isolated from mangrove ecosystem and its potential for squalene production was assessed. When Rhodosporidium sp. DR37 was cultivated on non-optimized medium (20 g/L glucose, 5 g/L peptone, 5 g/L YE, 15 g/L agar, seawater (50% v/v), pH 7, 30 °C), 64 mg/L of squalene was produced. Significantly, use of optimized medium (20 g/L sucrose, 5 g/L peptone, seawater (20 % v/v), pH 7, 25 °C) allowed highest squalene accumulation in Rhodosporidium sp. DR37 (619 mg/L). The maximum squalene content was obtained as 21.6% of total lipid in comparison to the non-optimized medium (13.9% of total lipid).Conclusions: This study is the first report to employ marine oleaginous Rhodosporidium sp. DR37 for accumulation of squalene in optimized medium. Our findings provide the potential of Rhodosporidium sp. DR37 for production of squalene as well as lipid and carotenoids for biofuel applications in large scale.
- 26 January 2021
- Published by Springer Nature in Research Square
Open AccessRhodosporidium Sp. DR37: A Novel Strain For Production of Squalene in Optimized Cultivation Conditions
Background: Rhodosporidium strain, a well-known oleaginous yeast, has been widely used as a platform for lipid and carotenoid production. However, the production of squalene for application in lipid-based biofuels is not reported in this strain. Here, we isolated and identified newly strain of Rhodosporidium sp. DR37 and investigated its potential for production of squalene under various cultivation conditions.Results: In the present study, Rhodosporidium sp. DR37 was isolated from mangrove ecosystem and its potential for squalene production was assessed. When Rhodosporidium sp. DR37 was cultivated on non-optimized medium (20 g/L glucose, 5 g/L peptone, 5 g/L YE, 15 g/L agar, seawater (50% v/v), pH 7, 30 °C), 64 mg/L of squalene was produced. Significantly, use of optimized medium (20 g/L sucrose, 5 g/L peptone, seawater (20 % v/v), pH 7, 25 °C) allowed highest squalene accumulation in Rhodosporidium sp. DR37 (619 mg/L). The maximum squalene content was obtained as 21.6% of total lipid in comparison to the non-optimized medium (13.9% of total lipid).Conclusions: This study is the first report to employ marine oleaginous Rhodosporidium sp. DR37 for accumulation of squalene in optimized medium. Our findings provide the potential of Rhodosporidium sp. DR37 for production of squalene as well as lipid and carotenoids for biofuel applications in large scale.
- Open Access
- 13 January 2020
- Published by MDPI AG in Biomedicines
- Vol. 8 (1) , 13
Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics
The blood–brain barrier (BBB) acts as a barrier to prevent the central nervous system (CNS) from damage by substances that originate from the blood circulation. The BBB limits drug penetration into the brain and is one of the major clinical obstacles to the treatment of CNS diseases. Nanotechnology-based delivery systems have been tested for overcoming this barrier and releasing related drugs into the brain matrix. In this review, nanoparticles (NPs) from simple to developed delivery systems are discussed for the delivery of a drug to the brain. This review particularly focuses on polymeric nanomaterials that have been used for CNS treatment. Polymeric NPs such as polylactide (PLA), poly (D, L-lactide-co-glycolide) (PLGA), poly (ε-caprolactone) (PCL), poly (alkyl cyanoacrylate) (PACA), human serum albumin (HSA), gelatin, and chitosan are discussed in detail.
- 13 January 2020
- Published by MDPI AG in Biomedicines
- Vol. 8 (1) , 13
Open AccessMultifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics
The blood–brain barrier (BBB) acts as a barrier to prevent the central nervous system (CNS) from damage by substances that originate from the blood circulation. The BBB limits drug penetration into the brain and is one of the major clinical obstacles to the treatment of CNS diseases. Nanotechnology-based delivery systems have been tested for overcoming this barrier and releasing related drugs into the brain matrix. In this review, nanoparticles (NPs) from simple to developed delivery systems are discussed for the delivery of a drug to the brain. This review particularly focuses on polymeric nanomaterials that have been used for CNS treatment. Polymeric NPs such as polylactide (PLA), poly (D, L-lactide-co-glycolide) (PLGA), poly (ε-caprolactone) (PCL), poly (alkyl cyanoacrylate) (PACA), human serum albumin (HSA), gelatin, and chitosan are discussed in detail.
- 2 April 2018
- Published by Springer Nature in Ionics
- Vol. 24 (12) , 4023-4031
Voltammetric determination of dopamine in the presence of tyrosine using graphite screen-printed electrode modified with graphene quantum dots
- 2 April 2018
- Published by Springer Nature in Ionics
- Vol. 24 (12) , 4023-4031
Voltammetric determination of dopamine in the presence of tyrosine using graphite screen-printed electrode modified with graphene quantum dots
- 2 November 2017
- Published by Wiley in Journal of Food Science
- Vol. 82 (11) , 2706-2718
Antigastric Cancer Bioactive Aurantiochytrium Oil Rich in Docosahexaenoic Acid: From Media Optimization to Cancer Cells Cytotoxicity Assessment
Dietary eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may have a role in contributing to the prevention or inhibition of some malignancies. DHA, the most important polyunsaturated fatty acid (PUFA) in fish and thraustochytrid oils, is known for its anticancer activity. However, antigastric cancer activity of thraustochytrid microbial oil is still unclear. In this investigation, 45 thraustochytrid strains were screened for the production of antigastric cancer oil. Cytotoxicity of 12 thraustochytrid oils was assessed by 3‐(4,5‐dimethythiazol‐ 2‐yl)‐2,5‐diphenyl tetrazolium bromide (MTT) on gastric cancer AGS cells. The most cytotoxic effect was related to the oil extracted from the qe‐4 strain with 45% cell cytotoxicity. Therefore, the Taguchi methodology was used to optimize this bioactive microbial oil. The amounts of biomass, oil, and DHA were increased to 10.32 g/L, 3.86 g/L, and 1390 mg/L, respectively. Furthermore, the use of glycerol in low saline medium enhanced the yield of DHA. Then, the cytotoxicity of thraustochytrids oil rich in DHA or C16 (0.5 to 10 mg/mL), was assessed on AGS cells. Only the oil that was rich in DHA showed an inhibitory effect (IC 50 ) on AGS cells (same as the standard DHA at 1.26 mg/mL). These new findings revealed that thraustochytrid derived oil rich in DHA, has an inhibitory effect on gastric cancer cells. Phylogenetic analysis showed that qe‐4 is related to the genus Aurantiochytrium (AN: KR091914) as a potential candidate for the production of bioactive oil. In conclusion, these results certainly support further investigations on this bioactive microbial oil as an additive for the fortification of food and dairy products. Practical Application: Thraustochytrid microbial oil rich in DHA, showed antigastric cancer activity comparable to that of pure DHA; indicating that this microbial bioactive omega‐3 oil rich in the very important PUFA (DHA), can be applied as an additive for the fortification of food and dairy products. Also, Aurantiochytrium sp. KR091914, as a GRAS microorganism, is a good producer of this bioactive oil.
- 2 November 2017
- Published by Wiley in Journal of Food Science
- Vol. 82 (11) , 2706-2718
Antigastric Cancer Bioactive Aurantiochytrium Oil Rich in Docosahexaenoic Acid: From Media Optimization to Cancer Cells Cytotoxicity Assessment
Dietary eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may have a role in contributing to the prevention or inhibition of some malignancies. DHA, the most important polyunsaturated fatty acid (PUFA) in fish and thraustochytrid oils, is known for its anticancer activity. However, antigastric cancer activity of thraustochytrid microbial oil is still unclear. In this investigation, 45 thraustochytrid strains were screened for the production of antigastric cancer oil. Cytotoxicity of 12 thraustochytrid oils was assessed by 3‐(4,5‐dimethythiazol‐ 2‐yl)‐2,5‐diphenyl tetrazolium bromide (MTT) on gastric cancer AGS cells. The most cytotoxic effect was related to the oil extracted from the qe‐4 strain with 45% cell cytotoxicity. Therefore, the Taguchi methodology was used to optimize this bioactive microbial oil. The amounts of biomass, oil, and DHA were increased to 10.32 g/L, 3.86 g/L, and 1390 mg/L, respectively. Furthermore, the use of glycerol in low saline medium enhanced the yield of DHA. Then, the cytotoxicity of thraustochytrids oil rich in DHA or C16 (0.5 to 10 mg/mL), was assessed on AGS cells. Only the oil that was rich in DHA showed an inhibitory effect (IC 50 ) on AGS cells (same as the standard DHA at 1.26 mg/mL). These new findings revealed that thraustochytrid derived oil rich in DHA, has an inhibitory effect on gastric cancer cells. Phylogenetic analysis showed that qe‐4 is related to the genus Aurantiochytrium (AN: KR091914) as a potential candidate for the production of bioactive oil. In conclusion, these results certainly support further investigations on this bioactive microbial oil as an additive for the fortification of food and dairy products. Practical Application: Thraustochytrid microbial oil rich in DHA, showed antigastric cancer activity comparable to that of pure DHA; indicating that this microbial bioactive omega‐3 oil rich in the very important PUFA (DHA), can be applied as an additive for the fortification of food and dairy products. Also, Aurantiochytrium sp. KR091914, as a GRAS microorganism, is a good producer of this bioactive oil.
- 1 September 2017
- Published by Elsevier in Journal of Molecular Liquids
- Vol. 242, 685-689
CoFe 2 O 4 nanoparticle/ionic liquid modified carbon paste electrode as an amplified sensor for epirubicin analysis as an anticancer drug
- 1 September 2017
- Published by Elsevier in Journal of Molecular Liquids
- Vol. 242, 685-689
CoFe 2 O 4 nanoparticle/ionic liquid modified carbon paste electrode as an amplified sensor for epirubicin analysis as an anticancer drug
- 25 August 2017
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 9 (37) , 5541-5549
GO/Fe 3 O 4 @SiO 2 core–shell nanocomposite-modified graphite screen-printed electrode for sensitive and selective electrochemical sensing of dopamine and uric acid
Herein, we report the construction of GO/Fe3O4@SiO2 core–shell nanocomposite-modified graphite screen-printed electrode that shows advantageous characteristics in terms of electrical conductivity, catalytic activity and surface area compared to bare screen-printed electrode. The designed sensor was used for the determination of dopamine and uric acid. Cyclic voltammetry, differential pulse voltammetry and chronoamperometry methods were used as the diagnostics techniques. Using the modified electrode, dopamine and uric acid were determined in the concentration ranges from 0.1 to 600.0 μM and 0.75 to 300.0 μM, respectively, whereas the detection limits were found to be 8.9 × 10−8 M and 5.7 × 10−7 M, respectively. Finally, real sample analysis was done successfully using the modified electrode.
- 25 August 2017
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 9 (37) , 5541-5549
GO/Fe 3 O 4 @SiO 2 core–shell nanocomposite-modified graphite screen-printed electrode for sensitive and selective electrochemical sensing of dopamine and uric acid
Herein, we report the construction of GO/Fe3O4@SiO2 core–shell nanocomposite-modified graphite screen-printed electrode that shows advantageous characteristics in terms of electrical conductivity, catalytic activity and surface area compared to bare screen-printed electrode. The designed sensor was used for the determination of dopamine and uric acid. Cyclic voltammetry, differential pulse voltammetry and chronoamperometry methods were used as the diagnostics techniques. Using the modified electrode, dopamine and uric acid were determined in the concentration ranges from 0.1 to 600.0 μM and 0.75 to 300.0 μM, respectively, whereas the detection limits were found to be 8.9 × 10−8 M and 5.7 × 10−7 M, respectively. Finally, real sample analysis was done successfully using the modified electrode.
- Top Cited Papers
- 1 December 2016
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 86, 879-884
Simultaneous determination of 6-mercaptopruine, 6-thioguanine and dasatinib as three important anticancer drugs using nanostructure voltammetric sensor employing Pt/MWCNTs and 1-butyl-3-methylimidazolium hexafluoro phosphate
- 1 December 2016
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 86, 879-884
Top Cited PapersSimultaneous determination of 6-mercaptopruine, 6-thioguanine and dasatinib as three important anticancer drugs using nanostructure voltammetric sensor employing Pt/MWCNTs and 1-butyl-3-methylimidazolium hexafluoro phosphate